Jose J Miguel-Hidalgo1, Angela Whittom2, Ashley Villarreal2, Madhav Soni2, Ashish Meshram2, Jason C Pickett2, Grazyna Rajkowska2, Craig A Stockmeier3. 1. Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA. Electronic address: Jmiguel-hidalgo@umc.edu. 2. Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA. 3. Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA; Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
Abstract
BACKGROUND: In major depressive disorder (MDD), lowered neural activity and significant reductions of markers of cell resiliency to degeneration occur in the prefrontal cortex (PFC). It is still unclear whether changes in other relevant markers of cell vulnerability to degeneration and markers of cell proliferation are associated with MDD. METHODS: Levels of caspase 8 (C8), X-linked inhibitor of apoptosis protein (XIAP), direct IAP binding protein with low pI (DIABLO), proliferating cell nuclear antigen (PCNA) and density of cells immunoreactive (-IR) for proliferation marker Ki-67 were measured in postmortem samples of the left orbitofrontal cortex (OFC) of subjects with MDD, and psychiatrically-normal comparison subjects. RESULTS: There was significant increase in C8, a higher ratio of DIABLO to XIAP, lower packing density of Ki-67-IR cells, and an unexpected age-dependent increase in PCNA in subjects with MDD vs. controls. PCNA levels were significantly higher in MDD subjects unresponsive to antidepressants or untreated with antidepressants. The DIABLO/XIAP ratio was higher in MDD subjects without antidepressants than in comparison subjects. LIMITATIONS: Qualitative nature of responsiveness assessments; definition of resistance to antidepressant treatment is still controversial; and unclear role of PCNA. CONCLUSIONS: Markers of cell vulnerability to degeneration are increased and density of Ki67-positive cells is low MDD, but accompanied by normal XIAP levels. The results suggest increased vulnerability to cell pathology in depression that is insufficient to cause morphologically conspicuous cell death. Persistent but low-grade vulnerability to cell degeneration coexisting with reduced proliferation readiness may explain age-dependent reductions in neuronal densities in the OFC of depressed subjects.
BACKGROUND: In major depressive disorder (MDD), lowered neural activity and significant reductions of markers of cell resiliency to degeneration occur in the prefrontal cortex (PFC). It is still unclear whether changes in other relevant markers of cell vulnerability to degeneration and markers of cell proliferation are associated with MDD. METHODS: Levels of caspase 8 (C8), X-linked inhibitor of apoptosis protein (XIAP), direct IAP binding protein with low pI (DIABLO), proliferating cell nuclear antigen (PCNA) and density of cells immunoreactive (-IR) for proliferation marker Ki-67 were measured in postmortem samples of the left orbitofrontal cortex (OFC) of subjects with MDD, and psychiatrically-normal comparison subjects. RESULTS: There was significant increase in C8, a higher ratio of DIABLO to XIAP, lower packing density of Ki-67-IR cells, and an unexpected age-dependent increase in PCNA in subjects with MDD vs. controls. PCNA levels were significantly higher in MDD subjects unresponsive to antidepressants or untreated with antidepressants. The DIABLO/XIAP ratio was higher in MDD subjects without antidepressants than in comparison subjects. LIMITATIONS: Qualitative nature of responsiveness assessments; definition of resistance to antidepressant treatment is still controversial; and unclear role of PCNA. CONCLUSIONS: Markers of cell vulnerability to degeneration are increased and density of Ki67-positive cells is low MDD, but accompanied by normal XIAP levels. The results suggest increased vulnerability to cell pathology in depression that is insufficient to cause morphologically conspicuous cell death. Persistent but low-grade vulnerability to cell degeneration coexisting with reduced proliferation readiness may explain age-dependent reductions in neuronal densities in the OFC of depressed subjects.
Authors: John G Albeck; John M Burke; Bree B Aldridge; Mingsheng Zhang; Douglas A Lauffenburger; Peter K Sorger Journal: Mol Cell Date: 2008-04-11 Impact factor: 17.970
Authors: Q L Deveraux; N Roy; H R Stennicke; T Van Arsdale; Q Zhou; S M Srinivasula; E S Alnemri; G S Salvesen; J C Reed Journal: EMBO J Date: 1998-04-15 Impact factor: 11.598
Authors: A M Verhagen; P G Ekert; M Pakusch; J Silke; L M Connolly; G E Reid; R L Moritz; R J Simpson; D L Vaux Journal: Cell Date: 2000-07-07 Impact factor: 41.582
Authors: Tiziano M Scarabelli; Anastasis Stephanou; Evasio Pasini; Gianluca Gitti; Paul Townsend; Kevin Lawrence; Carol Chen-Scarabelli; Louis Saravolatz; David Latchman; Richard Knight; Julius Gardin Journal: J Am Coll Cardiol Date: 2004-03-03 Impact factor: 24.094
Authors: Mounira Banasr; Gerald W Valentine; Xiao-Yuan Li; Shannon L Gourley; Jane R Taylor; Ronald S Duman Journal: Biol Psychiatry Date: 2007-06-21 Impact factor: 13.382
Authors: Natalya A Uranova; Victor M Vostrikov; Diana D Orlovskaya; Valentina I Rachmanova Journal: Schizophr Res Date: 2004-04-01 Impact factor: 4.939
Authors: Gouri J Mahajan; Eric J Vallender; Michael R Garrett; Lavanya Challagundla; James C Overholser; George Jurjus; Lesa Dieter; Maryam Syed; Damian G Romero; Hamed Benghuzzi; Craig A Stockmeier Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2017-11-22 Impact factor: 5.067
Authors: José Javier Miguel-Hidalgo; Katherine O Hall; Hannah Bonner; Anna M Roller; Maryam Syed; Casey J Park; Jana P Ball; Marc E Rothenberg; Craig A Stockmeier; Damian G Romero Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2017-08-09 Impact factor: 5.067